BiotechTube

Omalizumab Injection

ApprovedRecruiting
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Food Allergy

Conditions

Food Allergy, Food Allergy in Children

Trial Timeline

Oct 1, 2024 → Dec 1, 2026

NCT ID
NCT06618963

About Omalizumab Injection

Omalizumab Injection is a approved stage product being developed by Roche for Food Allergy. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06618963. Target conditions include Food Allergy, Food Allergy in Children.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT06618963ApprovedRecruiting

Competing Products

17 competing products in Food Allergy

See all competitors
ProductCompanyStageHype Score
Milademetan Treatment A + Milademetan Treatment B + Milademetan Treatment CDaiichi SankyoPhase 1
33
E7386EisaiPhase 1
33
AZD7986, oral solution, 1 to 50 mg/mL + Placebo, oral solutionAstraZenecaPhase 1
33
AcalabrutinibAstraZenecaPhase 2
52
esomeprazole/ASA Fixed Dose Combination (FDC)AstraZenecaPhase 1
33
Ligelizumab 120 mg + Ligelizumab 240 mgNovartisPhase 3
77
OmalizumabNovartisApproved
85
Glucopyranosyl Lipid A (GLA) + Sublingual Immuno Therapy (SLIT) Peanut Extract (PE) + Placebo for GLA + Placebo for SLIT PESanofiPhase 1
32
DupilumabRegeneron PharmaceuticalsPre-clinical
22
linvoseltamab + dupilumabRegeneron PharmaceuticalsPhase 1
32
DupilumabRegeneron PharmaceuticalsPhase 2
51
Sativex + Sativex + Sativex + SativexJazz PharmaceuticalsPhase 1
30
fruquintinibHUTCHMEDPhase 1
28
VolitinibHUTCHMEDPhase 1
28
Viaskin Milk 150 mcg + Viaskin Milk 300 mcg + Viaskin Milk 500 mcg + Viaskin PlaceboDBV TechnologiesPhase 1/2
36
AZD1722 salt tablet + AZD1722 free base tablet + AZD1722 free base tablet + OmeprazoleArdelyxPhase 1
28
E. Coli-Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3Allergy TherapeuticsPhase 1
28

Other Products from Roche

EmicizumabApproved
85
rituximab + methotrexate + methylprednisolone + acetaminophen + antihistamineApproved
85
RituximabApproved
85
mycophenolate mofetil [CellCept]Approved
85
saquinavir/ritonavir + atazanavir/ritonavirApproved
85